Dr. Andy Rohrwasser's passions and interests are rare and ultrarare disorders and how to diagnose patients before the onset of symptoms to avoid treatment delays, alleviate unnecessary suffering and control costs.
Andy's professional interests are focused on innovation, scalability, and cost effectiveness solutions in newborn screening and public health services at large. Operationally, his work focuses on how emerging biochemical, genetic and IT technologies can be rapidly applied to significantly expand and improve public service programs